Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs ArcelorMittal SA — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while ArcelorMittal SA trades at $62.75 (market cap $47.40B). The key difference: ArcelorMittal SA is far larger — about 6.7× Ionis Pharmaceuticals Inc. Common Stock's market cap, and ArcelorMittal SA pays a 0.96% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and ArcelorMittal SA for 36 Days on average.
| IONS | MT | |
|---|---|---|
Market Cap | $7.10B | $47.40B |
Volume | 2,027,457 | 869,267 |
Sector | Health | Basic Materials |
52-Week High | $86.50 | $78.74 |
52-Week Low | $42.38 | $36.91 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $6.66B | $56.97B |
Dividend Yield | — | 0.96% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ArcelorMittal (MT) trades at $63.47, up 0.83% with a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals with declining revenue from $79.8B in 2022 to $61.4B in 2025, though net income improved to $3.2B. Recent Ukraine plant impairments and missile strikes create operational headwinds, while analyst consensus remains bullish with a $74.33 price target representing 17% upside potential.
MT offers value with attractive valuation ratios (P/S 0.77, P/B 0.87) and strong cash flow generation, but faces significant geopolitical risks and declining revenue trends. The company's strategic shift toward regional operations and shareholder returns provides upside, though investors must weigh Ukraine-related impairments and steel demand volatility against the positive analyst sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
